← Leaderboards
Hong Chen
Boston Children'S Hospital
$23,928,447
Attributed
$47,697,668
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.5M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$47,697,668 · 16
By mechanism
R01$47,666,168 · 15
R13$31,500 · 1
Top collaborators
- Da-Zhi Wang14 shared
- Sanjay Srivastava12 shared
- James Brandon Dixon9 shared
- Jinjun Shi9 shared
- Rajanarayanan S Srinivasan9 shared
- Jian Xu8 shared
- Diane Renee Bielenberg5 shared
- Yabing Chen4 shared
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Jinjun Shi$13,516,816
- John Y-J Shyy$24,226,917
- Yang Lee$76,767
- Diane Renee Bielenberg$4,392,792
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularMediatingSignal TransductionEpsinPlayEndothelial CellsAdaptor Signaling ProteinCardiovascular DiseasesIn VitroPreventMissionIn VivoEndotheliumMouse ModelUnited States National Institutes Of HealthInnovationTargeted TreatmentAtherosclerosisUnited StatesCause Of DeathBindingEpsin 1Pathway InteractionsLipids
Grant awards (70)
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease$870,663
R01 · FY2025 · HL · contact PI
Controlling Neuropilin-2 Signaling to Improve Lymphatic Function$865,694
R01 · FY2025 · HL
A New-Generation Lipid-Lowering and Anti-Inflammatory siRNA Therapy for Atherosclerosis$787,453
R01 · FY2025 · HL
Targeting Endothelial Epsins to Ameliorate Myocardial Ischemia$775,931
R01 · FY2025 · HL · contact PI
The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis$734,885
R01 · FY2025 · HL · contact PI
Role of PXR in drug-elicited cardiovascular disease$712,001
R01 · FY2025 · HL
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease$853,248
R01 · FY2024 · HL · contact PI
Targeting Endothelial Epsins to Ameliorate Myocardial Ischemia$833,681
R01 · FY2024 · HL · contact PI
The role of signaling adaptor protein epsin in atherosclerosis$770,203
R01 · FY2024 · HL · contact PI
Molecular Mechanisms Governing Vascular Cell Function and Phenotype in Health and Disease$728,548
R01 · FY2024 · HL · contact PI
The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis$722,635
R01 · FY2024 · HL · contact PI
Role of PXR in drug-elicited cardiovascular disease$697,761
R01 · FY2024 · HL
2024 Lymphatics Gordon Research Conference and Seminar$31,500
R13 · FY2024 · HL · contact PI
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease$870,663
R01 · FY2023 · HL · contact PI
CD45-mediated endothelial-to-mesenchymal transition in cardiovascular disease$838,978
R01 · FY2023 · HL · contact PI
Mechanisms regulating VEGF receptors in diabetic angiogenesis$814,512
R01 · FY2023 · HL · contact PI
The role of signaling adaptor protein epsin in atherosclerosis$785,922
R01 · FY2023 · HL · contact PI
The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis$769,426
R01 · FY2023 · HL · contact PI
Molecular Mechanisms Governing Vascular Cell Function and Phenotype in Health and Disease$743,417
R01 · FY2023 · HL · contact PI
Role of PXR in drug-elicited cardiovascular disease$725,876
R01 · FY2023 · HL
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease$928,413
R01 · FY2022 · HL · contact PI
CD45-mediated endothelial-to-mesenchymal transition in cardiovascular disease$838,978
R01 · FY2022 · HL · contact PI
Molecular Regulation of Atherosclerosis$822,688
R01 · FY2022 · HL · contact PI
Mechanisms regulating VEGF receptors in diabetic angiogenesis$814,512
R01 · FY2022 · HL · contact PI
The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis$812,576
R01 · FY2022 · HL · contact PI
The role of signaling adaptor protein epsin in atherosclerosis$785,718
R01 · FY2022 · HL · contact PI
Molecular Mechanisms Regulating Neuropilin 2 in Lymphangiogenesis$763,788
R01 · FY2022 · HL
Molecular Mechanisms Governing Vascular Cell Function and Phenotype in Health and Disease$743,417
R01 · FY2022 · HL · contact PI
Epsin in Angiogenesis and Vascular Remodeling$882,499
R01 · FY2021 · HL · contact PI
CD45-mediated endothelial-to-mesenchymal transition in cardiovascular disease$838,978
R01 · FY2021 · HL · contact PI
Molecular Regulation of Atherosclerosis$822,688
R01 · FY2021 · HL · contact PI
Mechanisms regulating VEGF receptors in diabetic angiogenesis$814,512
R01 · FY2021 · HL · contact PI
The role of signaling adaptor protein epsin in atherosclerosis$796,770
R01 · FY2021 · HL · contact PI
Molecular Mechanisms Governing Vascular Cell Function and Phenotype in Health and Disease$778,067
R01 · FY2021 · HL · contact PI
Molecular Mechanisms Regulating Neuropilin 2 in Lymphangiogenesis$765,490
R01 · FY2021 · HL
Epsin in Angiogenesis and Vascular Remodeling$882,499
R01 · FY2020 · HL · contact PI
Mechanisms regulating VEGF receptors in diabetic angiogenesis$833,762
R01 · FY2020 · HL · contact PI
Molecular Regulation of Atherosclerosis$822,688
R01 · FY2020 · HL · contact PI
Molecular Mechanisms Regulating Neuropilin 2 in Lymphangiogenesis$779,178
R01 · FY2020 · HL
CD45-mediated endothelial-to-mesenchymal transition in cardiovascular disease$762,210
R01 · FY2020 · HL · contact PI
Molecular Mechanisms Regulating Endothelial Dysfunction$676,330
R01 · FY2020 · HL · contact PI
Epsin in Angiogenesis and Vascular Remodeling$882,499
R01 · FY2019 · HL · contact PI
Molecular Regulation of Atherosclerosis$880,438
R01 · FY2019 · HL · contact PI
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease$794,061
R01 · FY2019 · HL · contact PI
Molecular Mechanisms Regulating Neuropilin 2 in Lymphangiogenesis$785,197
R01 · FY2019 · HL
Molecular Mechanisms Regulating Endothelial Dysfunction$676,330
R01 · FY2019 · HL · contact PI
Mechanisms regulating VEGF receptors in diabetic angiogenesis$405,886
R01 · FY2019 · HL · contact PI
Epsin in Angiogenesis and Vascular Remodeling$883,049
R01 · FY2018 · HL · contact PI
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease$721,973
R01 · FY2018 · HL · contact PI
Molecular Mechanisms Regulating Endothelial Dysfunction$676,330
R01 · FY2018 · HL · contact PI
Mechanisms regulating VEGF receptors in diabetic angiogenesis$407,638
R01 · FY2018 · HL · contact PI
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease$72,083
R01 · FY2018 · HL · contact PI
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease$780,654
R01 · FY2017 · HL · contact PI
Molecular Mechanisms Regulating Endothelial Dysfunction$695,580
R01 · FY2017 · HL · contact PI
Epsin in Angiogenesis and Vascular Remodeling$442,500
R01 · FY2017 · HL · contact PI
"The Role of Signaling Adaptor Protein Epsin in Atherosclerosis"$441,262
R01 · FY2017 · HL · contact PI
Mechanisms regulating VEGF receptors in diabetic angiogenesis$414,634
R01 · FY2017 · HL · contact PI
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease$760,461
R01 · FY2016 · HL · contact PI
Epsin in Angiogenesis and Vascular Remodeling$442,500
R01 · FY2016 · HL · contact PI
"The Role of Signaling Adaptor Protein Epsin in Atherosclerosis"$434,643
R01 · FY2016 · HL · contact PI
Mechanisms regulating VEGF receptors in diabetic angiogenesis$433,884
R01 · FY2016 · HL · contact PI
"The Role of Signaling Adaptor Protein Epsin in Atherosclerosis"$426,318
R01 · FY2015 · HL · contact PI
Epsin in Angiogenesis and Vascular Remodeling$422,318
R01 · FY2015 · HL · contact PI
The Role of Signaling Adaptor Protein Epsin in Atherosclerosis$453,013
R01 · FY2014 · HL · contact PI
Epsin in Angiogenesis and Vascular Remodeling$427,500
R01 · FY2014 · HL · contact PI
Epsin in angiogenesis and vascular remodeling$395,622
R01 · FY2013 · HL · contact PI
Epsin in angiogenesis and vascular remodeling$403,648
R01 · FY2012 · HL · contact PI
Epsin in angiogenesis and vascular remodeling$407,719
R01 · FY2011 · HL · contact PI
Epsin in angiogenesis and vascular remodeling$414,858
R01 · FY2010 · HL · contact PI
Epsin in angiogenesis and vascular remodeling$416,312
R01 · FY2009 · HL · contact PI